When Mayne did deal with Mithra sp was 51c.
After all the uplifting positive comments from
both CEOS. Richards and Fornieri it was 63c.
Now with Nextellis approval granted FDA sales
been happening since June. SP has halved to 31.5c today. Am I wrong to be a little sceptical?
I really do believe it is leadership and management being the major obstacles in progress of Mayne. Birds of a Feather may be
appropriate for these two individuals. We all know where Fornieri is at. Rich but not a happy
place.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$5.05 |
Change
0.050(1.00%) |
Mkt cap ! $410.2M | |||
| Open | High | Low | Value | Volume |
| $5.05 | $5.09 | $4.96 | $430.0K | 85.55K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 533 | $5.04 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.06 | 3136 | 6 |
View Market Depth
| Last trade - 14.44pm 25/06/2025 (20 minute delay) ? |
| MYX (ASX) Chart |